原创《蒙脱石散和双歧杆菌三联活菌颗粒治疗小儿腹泻临床对比》：本文是一篇关于双歧杆菌论文范文，可作为相关选题参考,和写作参考文献。
【摘 要】 目的 探讨蒙脱石散及双歧杆菌三联活菌颗粒治疗小儿腹泻的临床疗效.方法 100例腹泻患儿, 根据治疗方法不同分为对照组和观察组, 每组50例.对照组患儿给予常规疗法联合蒙脱石散治疗, 观察组患儿给予常规疗法联合双歧杆菌三联活菌颗粒治疗.观察两组患儿的临床治疗效果.
结果 观察组患儿的治疗总有效率为98.0%, 对照组患儿为86.0%, 两组患儿治疗总有效率比较差异有统计学意义（P<0.05）.观察组患儿的腹泻持续时间显著短于对照组, 差异具有统计学意义（P<0.01）.两组患儿不良反应发生率比较差异无统计学意义（P>0.05）.结论 和蒙脱石散比较, 双歧杆菌三联活菌颗粒用于小儿腹泻治疗中的效果更好, 利于促进患儿腹泻症状缓解, 且用药方法简单, 值得推广.
【关键词】 蒙脱石散；双歧杆菌三联活菌颗粒；小儿腹泻
DOI：10.14163/j.cnki.11-5547/r.2017.34.055
A clinical comparative study of montmorillonite powder and bifid triple viable granule in the treatment of infantile diarrhea CHEN Zhi-chang. Houjie Town Community Health Service Center, Dongguan 523960, China
【Abstract】 Objective To discuss the clinical efficacy of montmorillonite powder and bifid triple viable granule in the treatment of infantile diarrhea. Methods A total of 100 diarrhea children were divided by different treatment methods into control group and observation group, with 50 cases in each group. The control group was treated with conventional therapy and montmorillonite powder, and the observation group was treated with conventional therapy and bifid triple viable granule. The clinical treatment effect in two groups was observed. Results The observation group had total treatment effective rate as 98.0%, which was 86.0% in the control group, and their difference was statistically significant （P<0.05）. The observation group had obviously shorter diarrhea duration than the control group, and the difference was statistically significant （P<0.01）. Both groups had no statistically significant difference in incidence of adverse reactions （P>0.05）. Conclusion Compared with montmorillonite powder, bifid triple viable granule shows better effect in treating infantile diarrhea. It can promote relief of diarrhea symptoms, and the medication method is simple. It is worthy of promotion.
【Key words】 Montmorillonite powder； Bifid triple viable granule； Infantile diarrhea
小兒腹泻一般是由胃肠道感染引起的, 采用微生态制剂可促进患儿肠道菌群平衡, 促进腹泻症状的缓解[1].蒙脱石散和双歧杆菌三联活菌颗粒是常用的微生态制剂, 现以本社区诊治的100例腹泻患儿为例, 探索二者的疗效.现报告
如下.
1 资料和方法
1. 1 一般资料 选取2015年1月～2017年4月本社区诊治的100例轮状病毒感染腹泻的患儿, 根据治疗方法不同分为观察组和对照组, 每组50例.对照组患儿中男29例, 女21例,
年龄1～7岁, 平均年龄（3.44±1.19）岁；病程0～3 d, 平均病程（1.27±0.58）d；腹泻次数3～7次/d, 平均次数（4.94±
0.69）次/d.观察组患儿中男32例, 女18例, 年龄1～8岁, 平均年龄（3.38±1.54）岁；病程0～3 d, 平均病程（1.35±0.55）d；腹泻次数4～7次/d, 平均次数（4.98±0.67）次/d.两组患儿一般资料比较差异无统计学意义（P>0.05）, 具有可比性.
1. 2 方法 两组患儿在入社区确诊后均给予常规对症疗法, 主要包括补液、预防感染、止吐、退热等.在此基础上对照组患儿给予蒙脱石散治疗, 对<3岁的患儿, 使用40℃温水冲2袋/d, 分成3次口服；对≥3岁的患儿口服3袋/d, 分成3次口服；观察组患儿给予双歧杆菌三联活菌颗粒治疗, 对<5岁的患儿, 1袋/次, 3次/d；对≥5岁的患儿, 2袋/次, 3次/d.
双歧杆菌论文参考资料：
结论：蒙脱石散和双歧杆菌三联活菌颗粒治疗小儿腹泻临床对比为关于本文可作为双歧杆菌方面的大学硕士与本科毕业论文益生菌哪个牌子好论文开题报告范文和职称论文论文写作参考文献下载。
